Stocks and Investing Stocks and Investing
Wed, June 9, 2021
Tue, June 8, 2021

Silvan Tuerkcan Initiated (TSHA) at Buy and Held Target at $40 on, Jun 8th, 2021


Published on 2024-10-27 16:55:55 - WOPRAI, Silvan Tuerkcan
  Print publication without navigation


Silvan Tuerkcan of JMP Securities, Initiated "Taysha Gene Therapies, Inc." (TSHA) at Buy and Held Target at $40 on, Jun 8th, 2021.

Silvan has made no other calls on TSHA in the last 4 months.



There are 4 other peers that have a rating on TSHA. Out of the 4 peers that are also analyzing TSHA, 0 agree with Silvan's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Silvan


  • Kristen Kluska of "Cantor Fitzgerald" Initiated at Buy and Held Target at $44 on, Wednesday, May 19th, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $43 on, Tuesday, April 13th, 2021
  • Gbola Amusa of "Chardan Capital" Maintained at Strong Buy with Increased Target to $68 on, Tuesday, April 13th, 2021
  • Raju Prasad of "William Blair" Initiated at Buy and Held Target at $46 on, Wednesday, February 24th, 2021
Contributing Sources